Sudarshan Pharma jumps 3% on NSE after strong Q4 results
Business
Sudarshan Pharma's stock got a nice boost on Monday, rising as much as 3% after the company posted strong results for January-March 2026.
Shares traded at ₹31 on the NSE, continuing a winning streak that's now stretched across two sessions.
Sudarshan Pharma Q4 profit 44.8% ₹10.73cr
The company's net profit for Q4 jumped 44.8% to ₹10.73 crore compared to last year, while revenue climbed 37% to ₹221 crore.
For all of FY26, profit soared by more than 55%, showing solid growth vibes.
The upbeat market mood, thanks to cheaper oil and a rally in auto stocks, also helped Sudarshan's shares gain.